IDEAYA Biosciences Inc CEO Yujiro Hata Sells 99,372 Shares [Yahoo! Finance]
IDEAYA Biosciences, Inc. (IDYA)
Last ideaya biosciences, inc. earnings: 3/24 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
The transaction was reported in a SEC Filing . Following this transaction, the insider's total sales over the past year amount to 250,000 shares, with no reported purchases in the same period. Warning! GuruFocus has detected 5 Warning Signs with IDYA. IDEAYA Biosciences Inc is a precision medicine company focused on the discovery and development of targeted therapies for cancer. The company aims to improve the lives of cancer patients by developing personalized therapeutics that are designed to address the specific genetic and immunological drivers of an individual's cancer. The insider transaction history for IDEAYA Biosciences Inc shows a pattern of insider selling, with 20 insider sells and no insider buys over the past year. On the day of the insider's recent sale, shares of IDEAYA Biosciences Inc were trading at $45.24, giving the company a market capitalization of $3.354 billion. The stock's price-to-GF-Value ratio stands at 5.32, indicating that IDEAYA Biosciences Inc
Show less
Read more
Impact Snapshot
Event Time:
IDYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IDYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IDYA alerts
High impacting IDEAYA Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
IDYA
News
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study [Yahoo! Finance]Yahoo! Finance
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored StudyPR Newswire
- IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer [Yahoo! Finance]Yahoo! Finance
- IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung CancerPR Newswire
IDYA
Earnings
- 5/9/23 - Beat
IDYA
Sec Filings
- 4/24/24 - Form ARS
- 4/19/24 - Form DEF
- 3/12/24 - Form 8-K
- IDYA's page on the SEC website